Thoracic Pathology Course is organized by United States and Canadian Academy of Pathology (USCAP) and will be held from Dec 12, 2018 - Oct 24, 2021.
Practicing academic and community pathologists, and pathologists-in-training
Continuing Medical Education and Continuing Certification:
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 14.75 SAM credit hours.
Thoracic specimens are commonly encountered in clinical practice derived from biopsy and surgical procedures on pulmonary, cardiovascular and mediastinal tissue. The panorama includes neoplasms and non-neoplastic entities. The fact that many of these require evaluation for medical diseases of the thorax provokes anxiety among pathologists, particularly where subspecialty pathologists are not readily available. The last five years contributed a dizzying array of updates in classification, nomenclature and reporting guidelines. Therefore, it’s time for pathologists to update their knowledge and skills in the diagnosis of thoracic pathology in an intimate mentoring environment that unites experienced experts with pathologists desiring a contemporary review of modern thoracic pathology.
Upon completion of this educational activity, learners will be able to:
• Understand the fundamental approaches to handling thoracic specimens
• Apply and recognize new classification/grading schemes regarding thoracic disease
• Recognize the importance of multidisciplinary (i.e., radiologic) collaboration in thoracic disease
• Identify clinically relevant diagnostic concepts to aid in patient management
• Utilize appropriate and minimum ancillary studies to diagnose and/or exclude lymphoproliferative processes
Additional details will be posted as soon as they are available.
Pathology, Thoracic Surgery